Gilead Sciences Stock

These 2 Pharma Stocks May Be in for Huge Gains Amid Coronavirus Pandemic

Coronavirus-Driven Market Puts Emphasis on Pharma Stocks As you'd expect during a pandemic, those who make medicine are among the best situated to eke out a profit, even as most other stocks tumble. Considering that gold and bonds and other traditional safe-haven investments are falling at the moment,…

Here’s How Best to Profit From the Market Downswing

Market Correction Presents Opportunity for Investors The stock market is in free fall right now. Between the novel coronavirus (COVID-19) causing global panic and the recent plunge in oil prices due to tensions between Saudi Arabia—and to a lesser extent the Organization of the Petroleum Producing Countries (OPEC)—and…

These Three Stocks Are Ready to See Big Gains From the Coronavirus

Coronavirus Causes Stock Market Shake-Up & Opportunity They say that every failure is an opportunity. That translates well to the stock market. While the coronavirus (also known as COVID-19) is largely causing share prices to fall, there are a number of companies that are poised to see huge…

Gilead Stock Surges and Shatters These Resistance Levels

GILD Stock: Bullish Developments Wow, Gilead Sciences, Inc. (NASDAQ:GILD) stock has just taken a serious turn, and the timing could not have been any better. In a June 14 publication titled "Gilead Stock Needs to Conquer These Hurdles," I focused on GILD stock and outlined the developments that I would…

Gilead Stock Needs to Conquer These Hurdles

GILD Stock: Bullish Optimism Gilead Sciences, Inc. (NASDAQ:GILD) stock has been caught in a funk. I have expressed my views on this investment on multiple occasions, and each time, I have come to the same bearish conclusion about Gilead stock. The purpose of this publication is to outline the…

This Gilead Stock Chart Warned That a Bear Was Lurking

GILD Stock Is Like a Falling Knife Gilead Sciences, Inc. (NASDAQ:GILD) reported earnings after the close of business on February 7, 2017 and even though the company managed to beat both on the top and bottom lines, GILD stock has been trading sharply lower by 9.53%. The forward…

Gilead Sciences, Inc.: This GILD Stock Chart Is a Must-See

GILD Stock: Potentially Bullish? It has been quite a disappointing year for Gilead Sciences, Inc. (NASDAQ:GILD) stock, as its performance year-to-date is -25%. This performance is not surprising, and I have outlined numerous times in my previous reports why I am bearish on Gilead stock . My bearish views are…

Gilead Sciences, Inc.: Why GILD Stock Could Surge 86%

Why GILD Stock Remains a Good Investment for Long-Term Investors Gilead Sciences, Inc. (NASDAQ:GILD) stock lost more than 27% of its value year-to-date. GILD stock went down from its highest level of $111.11 per share to as low as $72.21 per share over the past 52 weeks. It…

Gilead Sciences, Inc.: GILD Stock Bears will Rejoice with This

GILD Stock: Simply Bearish Technical analysis is the method of discerning stock price trends and forecasting future price moves based on historical price data. Using this method, I have come to a trading bias with regards to Gilead Sciences, Inc. (NASDAQ:GILD). For those who are long, I am…

GILD Stock: This Could Be a Big Problem for Gilead Sciences, Inc.

GILD Stock: Value Trap? Gilead Sciences, Inc. (NASDAQ:GILD) stock is a heavyweight in the biotech space; the company bolsters a $105.0-billion market cap and ranks high among its competitors like GlaxoSmithKline plc (NYSE:GSK) and Pfizer Inc. (NYSE:PFE). The biotech space has been known to make and break many…

GILD Stock: Is This Tiny Company the Next Gilead Sciences, Inc.?

GILD Stock: The Competition Has a Leg Up There is nothing that can quite describe the feeling of doing fundamental due diligence on an investment, weighing its merits, and finally pulling the trigger only to have zero returns as a result. The disappointment is compounded when markets are…